HuGE Literature Finder
Records
1
-
30
| Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer. Cytokine 2022 Sep 160 156024. Padala Chiranjeevi, Puranam Kaushik, Shyamala Nivas, Kupsal Keerthi, Kummari Ramanjaneyulu, Galimudi Rajesh Kumar, Gundapaneni Kishore Kumar, Tupurani Mohini Aiyengar, Suryadevera Aparna, Chinta Sanjeeva Kumari, Manavathi Bramanandam, Hanumanth Surekha Ra |
| Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma. Journal of clinical medicine 2022 Sep 11 (19): . Bounous Valentina Elisabetta, Ferrero Annamaria, Campisi Paola, Fuso Luca, Pezua Sanjinez Jeremy Oscar Smith, Manassero Sabrina, De Rosa Giovanni, Biglia Nicolet |
| Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study. Gene 2022 Feb 820 146288. Kanabekova Perizat, Al-Awadi Amina M, Bauyrzhanova Zhansaya, Tahtouh Tania, Sarray Sameh, Almawi Wassim |
| Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies. PloS one 2022 17 (7): e0271265. Zhou Chen, Zou Xiangman, Wen Xiaosha, Guo Zif |
| Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women. Breast cancer (Tokyo, Japan) 2020 Nov . Kawada Kengo, Taira Naruto, Mizoo Taeko, Suzuki Yoko, Kajiwara Yukiko, Hatono Minami, Tsukioki Takahiro, Kochi Mariko, Abe Yuko, Nishiyama Keiko, Iwamoto Takayuki, Ikeda Hirokuni, Shien Tadahiko, Doihara Hiroyoshi, Ishihara Setsuko, Kawai Hiroshi, Kawasaki Kensuke, Ishibe Yoichi, Ogasawara Yutaka, Toyooka Shinic |
| Genetic 3'UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients. Scientific reports 2020 Mar 10 (1): 5736. Pamula-Pilat Jolanta, Tecza Karolina, Kalinowska-Herok Magdalena, Grzybowska E |
| MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia. BMC cancer 2020 Mar 20 (1): 234. Floris Matteo, Sanna Daria, Castiglia Paolo, Putzu Carlo, Sanna Valeria, Pazzola Antonio, De Miglio Maria Rosaria, Sanges Francesca, Pira Giovanna, Azara Antonio, Lampis Emanuele, Serra Antonello, Carru Ciriaco, Steri Maristella, Costanza Flavia, Bisail Marco, Muroni Maria Rosar |
| Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2020 Feb 28 (2): 215-219. Zeliha Kara Pala, Dilek Ozturk, Ezgi Oztas, Halil Kara, Cihan Uras, Gul Ozh |
| Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer. Hormones & cancer 2020 Jan . Fowler Amy M, Salem Kelley, DeGrave Michael, Ong Irene M, Rassman Shane, Powers Ginny L, Kumar Manoj, Michel Ciara J, Mahajan Aparna |
| TP53 rs1042522 polymorphism and early-onset breast cancer. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2020 25 25. Icen-Taskin Irmak, Irtegun-Kandemir Sevgi, Munzuroglu Om |
| Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia. Endocrine, metabolic & immune disorders drug targets 2019 11 . Albalawi Ibrahim Altedlawi, Mir Rashid, Abu-Duhier F |
| BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management. The breast journal 2018 Jul . Loi Mauro, Desideri Isacco, Olmetto Emanuela, Francolini Giulio, Greto Daniela, Bonomo Pierluigi, Simontacchi Gabriele, Di Brina Lucia, Meattini Icro, Livi Loren |
| Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study. Pathology oncology research : POR 2018 Jan . Ghali Rabeb M, Al-Mutawa Maryam A, Ebrahim Bashayer H, Jrah Hanen H, Zaied Sonia, Bhiri Hanen, Hmila Fahmi, Mahjoub Touhami, Almawi Wassim |
| The Alu-insertion progesterone receptor gene polymorphism is not associated with breast cancer: a meta-analysis. BMC medical genetics 2018 Jan 19 (1): 16. Yao Jun, Qi Xing-Ling, Zhang Yo |
| Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing. Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
| Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2017 Dec . Tang Li, Platek Mary E, Yao Song, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Wu Yue, Platz Elizabeth A, Neuhouser Marian L, Stanczyk Frank Z, Reichardt Juergen K V, Santella Regina M, Hsing Ann, Figg William D, Lippman Scott M, Thompson Ian M, Ambrosone Christine |
| No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis. BMC medical genetics 2017 Oct 18 (1): 123. Qi Xing-Ling, Yao Jun, Zhang Yo |
| An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. Breast cancer (Dove Medical Press) 2017 9 95-110. Koleck Theresa A, Bender Catherine M, Clark Beth Z, Ryan Christopher M, Ghotkar Puja, Brufsky Adam, McAuliffe Priscilla F, Rastogi Priya, Sereika Susan M, Conley Yvette |
| ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors. Physiological genomics 2016 Aug physiolgenomics.00065.2016. Hertz Daniel L, Henry N Lynn, Kidwell Kelley M, Thomas Dafydd, Goddard Audrey, Azzouz Faouzi, Speth Kelly, Li Lang, Banerjee Mousumi, Thibert Jacklyn N, Kleer Celina G, Stearns Vered, Hayes Daniel F, Skaar Todd, Rae James |
| Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes. Breast cancer research and treatment 2016 Jul . Kotoula Vassiliki, Karavasilis Vasilios, Zagouri Flora, Kouvatseas George, Giannoulatou Eleni, Gogas Helen, Lakis Sotiris, Pentheroudakis George, Bobos Mattheos, Papadopoulou Kyriaki, Tsolaki Eleftheria, Pectasides Dimitrios, Lazaridis Georgios, Koutras Angelos, Aravantinos Gerasimos, Christodoulou Christos, Papakostas Pavlos, Markopoulos Christos, Zografos George, Papandreou Christos, Fountzilas Geor |
| LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome. Molecular oncology 2016 Jul . Ramirez-Ardila Diana E, Ruigrok-Ritstier Kirsten, Helmijr Jean C, Look Maxime P, van Laere Steven, Dirix Luc, Berns Els M J J, Jansen Maurice P H |
| Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression. PloS one 2016 11 (5): e0154789. Templeton Arnoud J, Gonzalez Laura Diez, Vera-Badillo Francisco E, Tibau Ariadna, Goldstein Robyn, Šeruga Boštjan, Srikanthan Amirrtha, Pandiella Atanasio, Amir Eitan, Ocana Alber |
| Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC cancer 2016 07 16 375. Gargiulo Piera, Pensabene Matilde, Milano Monica, Arpino Grazia, Giuliano Mario, Forestieri Valeria, Condello Caterina, Lauria Rossella, De Placido Sabi |
| HER2 mutation status in Japanese HER2-positive breast cancer patients. Breast cancer (Tokyo, Japan) 2015 Dec . Endo Yumi, Dong Yu, Kondo Naoto, Yoshimoto Nobuyasu, Asano Tomoko, Hato Yukari, Nishimoto Mayumi, Kato Hiroyuki, Takahashi Satoru, Nakanishi Ryoichi, Toyama Tatsu |
| A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Nov . Ma Cynthia X, Luo Jingqin, Naughton Michael, Ademuyiwa Foluso O, Suresh Rama, Griffith Malachi, Griffith Obi L, Skidmore Zachary, Spies Nicholas C, Ramu Avinash, Trani Lee, Pluard Timothy, Nagaraj Gayathri, Thomas Shana N, Guo Zhanfang, Hoog Jeremy, Han Jing, Mardis Elaine R, Lockhart A Craig, Ellis Matthew |
| Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast cancer research and treatment 2015 Oct . Haddad Stephen A, Lunetta Kathryn L, Ruiz-Narváez Edward A, Bensen Jeannette T, Hong Chi-Chen, Sucheston-Campbell Lara E, Yao Song, Bandera Elisa V, Rosenberg Lynn, Haiman Christopher A, Troester Melissa A, Ambrosone Christine B, Palmer Julie |
| Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer. European journal of endocrinology / European Federation of Endocrine Societies 2015 Jul 173 (1): 29-36. Vannucchi Guia, De Leo Simone, Perrino Michela, Rossi Stefania, Tosi Delfina, Cirello Valentina, Colombo Carla, Bulfamante Gaetano, Vicentini Leonardo, Fugazzola Lau |
| Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting. Polish journal of pathology : official journal of the Polish Society of Pathologists 2015 Jun 66 (2): 133-41. Adamczyk Agnieszka, Niemiec Joanna, Janecka Anna, Harazin-Lechowska Agnieszka, Ambicka Aleksandra, Grela-Wojewoda Aleksandra, Domaga?a-Haduch Ma?gorzata, Cedrych Ida, Majchrzyk Kaja, Kruczak Anna, Ry? Janusz, Jakubowicz Jer |
| Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study. PloS one 2015 10 (10): e0140293. Papaxoinis George, Kotoula Vassiliki, Alexopoulou Zoi, Kalogeras Konstantine T, Zagouri Flora, Timotheadou Eleni, Gogas Helen, Pentheroudakis George, Christodoulou Christos, Koutras Angelos, Bafaloukos Dimitrios, Aravantinos Gerasimos, Papakostas Pavlos, Charalambous Elpida, Papadopoulou Kyriaki, Varthalitis Ioannis, Efstratiou Ioannis, Zaramboukas Thomas, Patsea Helen, Scopa Chrisoula D, Skondra Maria, Kosmidis Paris, Pectasides Dimitrios, Fountzilas Geor |
| Contribution of PGR genetic polymorphisms to the pathogenesis of endometrial cancer: A meta-analysis. Journal of cancer research and therapeutics 0 11 (4): 810-7. Chen Zhen, Wang Shu-He, Zhou Jun, Wu Tao, Li J |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: